Report initial results from Part 2 of the AGI-134 Phase 1/2a trial in solid tumors
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 23 Feb 2021
- Due
- 31 Dec 2021
- Checked
- 26 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initial results from Part 2 of the Phase 1/2a trial of AGI-134 in solid tumors in the second half of 2021.”
What we found
Evidence strength A What the grades mean
After the 2021 deadline passed, filings from January to May 2022 moved the Part 2 initial results to H1 2022, then H2 2022. No results were reported by the deadline.
-
A BioLineRx Ltd. 6-K filed 2022-01-24
“Initial results anticipated in the first half of 2022” ✓ confirmed on the page
-
A BioLineRx Ltd. 6-K filed 2022-03-16
“Announce initial results for Part 2 of Phase 1/2a trial of AGI-134 in solid tumors in H2 2022” ✓ confirmed on the page
-
A BioLineRx Ltd. 6-K filed 2022-05-11
“Initial results from Part 2 of Phase 1/2a trial of AGI-134 in solid tumors in H2 2022” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Initial Part 2 results of AGI-134 Phase 1/2a trial
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you BioLineRx Ltd.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-BLRX-024231 · Corrections policy